SingHealth Polyclinics will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Dr OKA I GUSTI NGURAH PRAWIRA SUARTHA

BSc (Biochemistry), MD, MMed (Family Medicine), MCFP(S)

Associate Consultant, Marine Parade Polyclinic

SingHealth Polyclinics SingHealth Polyclinics

Conditions Treated By This Doctor

Clinical Appointments

Associate Consultant, Marine Parade Polyclinic

Academic Appointments

Clinical instructor, Duke-NUS Medical School, 2024 to date

Acting clinical core faculty, SingHealth Family Medicine Residency Training Program, 2024

GDFM tutor, College of Family Physicians Singapore, 2023- 2025

About Doctor

Dr. I Gusti Ngurah Prawira Suartha Oka is an Associate Consultant Family Physician currently practicing at SingHealth Polyclinics- Marine Parade.   Dr. Oka completed his training through the SingHealth Family Medicine Residency Program and was awarded the SingHealth RiSE Outstanding Resident Award in 2021. In recognition of his leadership abilities, Dr. Oka served as Chief Resident in the 6th SingHealth Residency Leadership Program.  After completing residency training, he has continued to deliver exemplary clinical care and was awarded the Singapore Health Quality Service Award (Silver) in 2023.  Beyond clinical practice, Dr. Oka actively engages in research and medical education. His notable research achievements include clinching awards at international research conferences and authoring several publications in reputable peer-reviewed journals.

Languages Spoken

  • English

Education and Training

  • FCFP(S), College of Family Physicians Singapore- 2025 
  • MCFP(S), College of Family Physicians Singapore- 2023 
  • MMed (Family Medicine), NUS- 2021  MD, Duke-NUS Medical School- 2017  
  • BSc (Biochemistry), University of Denver- 2013

Professional Appointments and Committee Memberships

  • Member, Future Planning Team, SingHealth Polyclinics, 2024 to date 
  • Grant reviewer, SingHealth Polyclinics Research Seed Fund and Collaborative Research Grants, 2023 to date 
  • Scholar, Asia Pacific Academic Primary Care Group , 2022 to date 
  • Member, Antimicrobial Stewardship Taskforce, SingHealth Polyclinics, 2021 to date 

Awards

  • 10th APPCRC Oral Presentation- Wock Heck Sing Award- 1st Place, 2025 
  • Singapore Health Quality Service Award- Silver, 2023 
  • SingHealth RiSE Award- Outstanding Resident Award, 2021 
  • 7th APPCRC Research Championships- 3rd, 2019 
  • 6th APPCRC Oral Presentation- Merit, 2017

Research Trials/Clinical Trials

Publications

  • Tan FCJH, Oka P, Dambha-Miller H, Tan NC. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. 2021;22(1).
  • Tan FCJH, Oka P, Dambha-Miller H, Tan NC. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. 2021;22(1).
  • Ng LP, Oka P, Lim CJF, Aau WK, Koh EYL, Ee AGL, et al. Crisis management in the community mass recall of angiotensin II receptor blocker losartan due to nitrosamine impurities. Proceedings of Singapore Healthcare. 2022;31.
  • Tan SY, Oka P, Tan NC. Intention to Vaccinate against COVID-19 in Adolescents: A Systematic Review. Vaccines. 2023;11(8):1393.
  • Oka P, Chong WM, Ng DX, Aau WK, Tan NC. Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study. Front Med (Lausanne). 2023;10.
  • Moosa AS, Oka P, Ng CJ. Exploring primary care physicians’ challenges in using home blood pressure monitoring to manage hypertension in Singapore: a qualitative study. Front Med (Lausanne). 2024;11
  • Oka P, Moosa AS, Ng CJ. Exploring the Challenges Faced by Primary Care Physicians in Providing Optimal Care for Patients With Hypertension: A Qualitative Study. Journal of Primary Care & Community Health. 2024;15.
  • Lim JY, Oka P, Ong L, Pitchay JBM, Ng WL. Prevalence of white coat hypertension (WCH) among individuals with elevated clinic blood pressure: A feasibility study. Proceedings of Singapore Healthcare. 2025;34. 
  • Ng WL, Tse ETY, Oka P, Lim HM, Koh SWC, Ramli R, Lau HC, Lam BCC, Goldsmith LJ, Abdullah A, Goh LH. HLA-B*58:01 screening in Asia-Pacific is an ethical imperative – not just a cost question. J Glob Health. 2025;15:03037.
  • Kumar S, Ng CJ, Oka P, Loke CY, Hong STS, Ng LP. Establishing Continuity of Care Through a Team-Based Care Approach: Implementation Challenges. Journal of Primary Care & Community Health. 2025;16. 
  • Oka P, Jia H, Kongsuphol P, Ng SY, Saravanan V, Ng CJ, et al. Seroprevalence of COVID-19 neutralizing antibodies among multi-ethnic staff of an Asian primary healthcare institution: insights from point-of-care testing and implications for booster vaccination decisions. BMC Infect Dis. 2025; 25:1450. 
  • Seng JJB, Cai M, Oka P. Rebound Pruritus and Urticaria Post-discontinuation of Chronic Cetirizine Use: A Case Report. Cureus. 2025;17(12): e100214.
  • Oka P, Moosa AS, Koh EYL, Ng CJ, Health and adverse events associated with extended oral bisphosphonates among postmenopausal women: a systematic review, The Journal of Clinical Endocrinology & Metabolism, 2026;, dgag057, https://doi.org/10.1210/clinem/dgag057